Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > High Purity QSC Ly3437943 Research Peptide 5mg 10mg GLP-1R Peptide Retatrutide.OUDA
High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA buy - large image1
High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA buy - image1
High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA buy - image2
High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA buy - image3
High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA buy - image4
High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA buy - image5
High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA buy - image6

High Purity QSC Ly3437943 Research Peptide 5mg 10mg GLP-1R Peptide Retatrutide.OUDA

TDS 7481 Inquiries

Unit Price:

$15/G FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Guangzhou

Brand:

YT

Packaging:

10mg/vial,10 vials/box

Price valid (until):

2027-12-31

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
2 days
Qualification:
Main Products:

Retatrutide,Sermaglutide,Tirzepatide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description

    Name:Lily

    Whatsapp:+86 19131996711

    Email Address:sales3ytpep@163.com


      Product Detail  


    What is Retatrutide?


    Retatrutide is a triple glucagon, GIP, and receptor agonist. Retatrutide showed glucose control and weight loss in patients with type 2 diabetes mellitus (T2DM).Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor . Retatrutide can be used for the research of obesity.Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual:Handling and Storage of Synthetic Peptides. Retatrutide is a new weight loss drug being experimented on by Eli Lilly, a pharmaceutical giant renowned for its breakthrough in diabetes and obesity treatment. Much like other weight loss drugs rolled out by Eli Lilly, Retatrutide is administered under the skin (subcutaneous route) per week and has yielded exceptional results in treating chronic diseases like diabetes and obesity compared to the predecessors.

    Function

    1. 1.Treatment of depression and anxiety disorders:  Retatrutide has been shown to have antidepressant and anxiolytic effects in preclinical studies, suggesting that it could be a promising treatment option for individuals with these conditions.
    2. 2.Prevention of neurodegenerative diseases:  Retatrutide  has neuroprotective properties that may be useful in preventing or slowing the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.
    3. 3.Enhancement of cognitive function:  Retatrutide has been shown to improve learning and memory in animal studies, suggesting that it could have potential as a cognitive enhancer in humans.
    4. 4.Treatment of chronic pain: Retatrutide has been shown to have analgesic effects in preclinical studies, suggesting that it could be a useful treatment option for individuals with chronic pain conditions.
    5. 5.Promotion of wound healing:  Retatrutide  has been shown to accelerate wound healing in animal studies, suggesting that it could have potential as a therapeutic agent for promoting wound healing in humans.

    Application

    1. Retatrutide is often used in the pharmaceutical industry, weight losing, etc.
    2. Retatrutide is a kind of peptide product.
    3. Retatrutide acetate can inhibited GCGR, GIPR and GLP-1R.
    4. Retatrutide acetate is activated by glucagon receptors resulting in significant weight loss and increased energy expenditure.
    5. Retatrutide acetate can be used in studies of obesity.

    Items Specifications
    Name Retatrutide
    CAS Number 2381089-83-2
    Apperance Powder

    Shop High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA-Detailed Image 1 Shop High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA-Detailed Image 2 Shop High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA-Detailed Image 3 Shop High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA-Detailed Image 4


    logistics 


    Customers can specify express delivery, such as:  UPS/DHL/FedEX , etc. (Default express delivery: our cooperative logistics company)

    Shop High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA-Detailed Image 5


    Company Profile  


    Yingpeptides Technology Co., Ltd focuses on the research and development and production of high potency polypeptide products, targeting the global market, and provides polypeptide API/raw material and preparation products. It has built polypeptide API workshops, bio-fermentation workshops, polypeptide purification and lyophilization workshops, and multifunctional injection workshops that meet the GMP requirements of mainstream markets such as the U.S. FDA, EU EMA, Japanese PMDA, and China NMPA. With the strong support of New Hope Group, the company has introduced advanced large-scale CS-PREP® industrial preparative liquid chromatography systems, becoming one of the few polypeptide companies in the industry with a capacity of tons.

    Shop High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA-Detailed Image 6 Shop High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA-Detailed Image 7 Shop High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA-Detailed Image 8 Shop High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA-Detailed Image 9


    Why choose us?


    Our Advantages.

    1.High quality with competitive price.

    2. All purity>99%.

    3. We are manufacturer and can provide high quality products with factory price.

    Shop High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA-Detailed Image 10


     How to order from us


    Shop High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA-Detailed Image 11

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Certificates
    • High Purity QSC Ly3437943 Research Peptide 5mg 10mg  GLP-1R Peptide Retatrutide.OUDA Certificates 1 TDS

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide,Sermaglutide,Tirzepatide

    Location:

    No. 126 Dongtai Road, Pudong New Area, Shanghai

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    2 days

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    11-50

    Year of Establishment:

    2025

         
          Yingpeptides Technology Co., Ltd focuses on the research and development and production of high potency polypeptide products, targeting the global market, and provides polypeptide API/raw material and preparation products. It has built polypeptide API workshops, bio-fermentation workshops, polypeptide purification and lyophilization workshops, and multifunctional injection workshops that meet the GMP requirements of mainstream markets such as the U.S. FDA, EU EMA, Japanese PMDA, and China NMPA. With the strong support of New Hope Group, the company has introduced advanced large-scale CS-PREP® industrial preparative liquid chromatography systems, becoming one of the few polypeptide companies in the industry with a capacity of tons.


  • Inquiry History
    7481 Inquiries
    Country Product Purchase Quantity Date Posted
    Greece

    Retatrutide

    30 MG Oct 27, 2026
    Germany

    Retatrutide

    20 MG Oct 27, 2026
    Canada

    Retatrutide

    30 MG Oct 27, 2026
    United States

    retatrutide

    40 MG Oct 27, 2026
    Spain

    Retatrutide

    30 MG Oct 27, 2026
    United Kingdom

    Retatrutide

    20 MG Oct 27, 2026
    United States

    Retatrutide

    40 MG Oct 27, 2026
    United States

    Retatrutide

    50 MG Oct 27, 2026
    United States

    retatrutide

    30 MG Oct 27, 2026
    United States

    retatrutide

    200 MG Oct 27, 2026
    Spain

    retatrutide

    200 MG Oct 27, 2026
    United States

    Retatrutide

    100 PCS Oct 27, 2026
    New Zealand

    Retatrutide

    20 PCS Oct 27, 2026
    Netherlands

    Retatrutide

    100 20' Fcl Oct 27, 2026
    United States

    Retatrutide

    300 MG Oct 27, 2026
    Canada

    Retatrutide

    1 G Oct 26, 2026
    Switzerland

    Retatrutide

    1 KG Oct 26, 2026
    United States

    Retatrutide

    10 MG Oct 26, 2026
    Australia

    Retatrutide

    30 MG Oct 26, 2026
    United States

    Retatrutide

    30 MG Oct 26, 2026
    Post an enquiry for this product

More from this Seller

pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.